Fetal skeletal dysplasias: genetic diagnosis and perinatal prognosis

Fetal skeletal dysplasias are a diverse group of conditions affecting bone growth, mineralisation, chest development and body proportions. Some are mild and compatible with a normal lifespan, while others cause severe pulmonary hypoplasia or major complications shortly after birth. Accurate assessment depends on combining ultrasound findings with family history, molecular testing and careful neonatal planning.

For families and clinicians in Australia, this work often involves several services: an obstetrician or maternal-fetal medicine specialist, a genetic counsellor, a fetal medicine sonographer, a paediatrician and, when needed, a neonatologist or orthopaedic specialist. The aim is to replace uncertainty with a realistic picture of diagnosis, treatment options, birth planning and the likely needs of the newborn.

Recognising the ultrasound pattern

A suspected skeletal dysplasia may first appear during the routine second-trimester morphology scan. Shortened long bones, an unusually small or narrow thorax, abnormal bone shape, reduced mineralisation, fractures, bowing, a small skull or unusual hand and foot posture can all be relevant. The pattern matters more than a single measurement, because some healthy fetuses are constitutionally small and have proportions that remain within a normal family range.

Serial ultrasound helps establish whether the limbs are becoming progressively shorter, whether the chest is growing adequately and whether the skull, spine and abdomen show additional abnormalities. Measurements are interpreted against gestational-age charts, with attention to femur and humerus length, head and abdominal circumference, thoracic dimensions and the relationship between different body regions. Three-dimensional ultrasound can provide useful surface detail, although it does not replace a full structural examination.

A detailed family history may reveal short stature, multiple miscarriages, unexplained neonatal deaths, fractures, joint problems or relatives with a known genetic condition. Consanguinity can increase the likelihood of recessive disease, while a previous affected pregnancy may point towards a recurrence risk that is much higher than the general population. A normal early scan does not exclude every disorder, since some skeletal conditions become recognisable only later in pregnancy.

Moving from suspicion to genetic diagnosis

The term skeletal dysplasia covers hundreds of disorders, including achondroplasia, thanatophoric dysplasia, osteogenesis imperfecta, campomelic dysplasia and conditions caused by abnormal bone mineralisation. Many arise from changes in genes involved in cartilage development, collagen production, intracellular transport or mineral metabolism. Some are inherited in an autosomal dominant, autosomal recessive or X-linked pattern; others result from a new variant in the fetus and are not inherited from either parent.

When ultrasound suggests a specific condition, targeted testing may provide a rapid answer. If the pattern is less distinctive, a skeletal dysplasia gene panel, prenatal exome sequencing or, in selected circumstances, broader genomic testing may be considered. Testing fetal DNA obtained through chorionic villus sampling or amniocentesis can be diagnostic, whereas non-invasive prenatal testing is currently much more useful for selected chromosomal conditions than for the full range of skeletal disorders.

The decision to test should be based on the clinical question, the gestational age, the possible effect on pregnancy management and the time needed to receive a result. Families need counselling before testing because a result may be definitive, uncertain or unexpectedly reveal information about parental health. A variant of uncertain significance should not be treated as proof of disease. Results should be interpreted alongside imaging and reviewed by a laboratory and clinical genetics team with relevant expertise.

For clinicians wanting wider context on perinatal research meetings and related international collaboration, the archived FAOPS 2020 congress provides background on the scientific setting in which fetal and neonatal medicine was discussed. Although the Tokyo meeting was cancelled during the COVID-19 pandemic, its subject area remains relevant to contemporary multidisciplinary care.

Estimating perinatal prognosis

Prognosis is often linked to the size and function of the fetal thorax. A very narrow chest, short ribs and severe reduction in lung volume can prevent effective breathing after birth. In such cases, death may occur despite intensive respiratory support. By contrast, a fetus with relatively preserved thoracic growth may have a good chance of survival even when the limbs are markedly shortened.

Other factors influence the outlook. Severe mineralisation defects can lead to fractures, poor bone strength and difficulties with handling or ventilation. Abnormal head growth may raise concerns about hydrocephalus or neurological complications. Some conditions increase the risk of cervical spine instability, airway compression, cardiac abnormalities or feeding problems. Prognostic discussions should therefore address the whole phenotype rather than rely on a diagnostic label alone.

The phrase “lethal dysplasia” is used cautiously because prenatal prediction is not perfect. Ultrasound findings can overlap between lethal and non-lethal disorders, and genetic results may refine but not always completely settle the forecast. A team may describe a range of likely outcomes, including survival with intensive neonatal care, prolonged respiratory support, surgery, mobility limitations or a shorter life expectancy.

In Australia, families may be referred to a tertiary centre in Melbourne, Sydney, Brisbane, Perth or Adelaide when specialised imaging, fetal MRI, invasive testing or neonatal intensive care is required. Travel from regional or remote communities can be demanding, so telehealth, coordinated appointments and clear written summaries are valuable. The practical burden of repeated scans, time away from work and childcare arrangements should form part of compassionate care.

Planning birth and newborn care

The delivery plan depends on the suspected diagnosis, gestational age, fetal condition and the family’s preferences. A planned birth at a hospital with maternal-fetal medicine, neonatal intensive care, paediatric respiratory expertise and access to genetics is appropriate when serious complications are possible. Vaginal birth is often feasible, but macrocephaly, bone fragility, malpresentation or obstetric indications may alter the plan. Caesarean birth does not prevent every complication and should be recommended for a clear maternal or fetal reason.

A neonatal team may prepare for difficult ventilation, airway management, fractures, hypoglycaemia, temperature instability and feeding problems. Some infants require continuous respiratory support, surgery or transfer to a specialist unit. When the expected condition is life-limiting, the plan may instead focus on comfort, family contact and avoiding invasive treatment that is unlikely to help. Palliative care can be involved before birth, alongside neonatal and obstetric teams, rather than only after deterioration.

Communication is especially important when the diagnosis remains uncertain. Families should receive a plain-language explanation of what is known, what is still unclear and which findings would change management. A written birth plan can record agreed resuscitation goals, who should be present, preferred communication arrangements and plans for collecting newborn blood or tissue for additional testing.

The pandemic also highlighted how quickly perinatal advice can change when infection risks affect pregnancy and newborn care. The archived discussion of vertical transmission evidence illustrates why families benefit from current, evidence-based counselling rather than relying on older online information. Infection prevention remains important, but it should not distract from the specific respiratory, skeletal and genetic needs of the infant.

Supporting families through decisions

A prenatal diagnosis can bring grief, anxiety, hope and uncertainty at the same time. Counselling should be non-directive and culturally safe, allowing families to consider continuing the pregnancy, preparing for neonatal treatment, arranging palliative care or discussing termination where it is legally available and clinically appropriate. Australian termination laws and access pathways differ between states and territories, so timely referral to local services is essential.

Families should also receive information about recurrence risk. A new dominant variant may carry a low recurrence risk for future pregnancies, although parental germline mosaicism means the risk is not always zero. Recessive conditions can carry a 25 per cent recurrence risk when both parents are carriers, while a maternal carrier of an X-linked condition may require a different counselling approach. If a causative variant is identified, options in a future pregnancy may include targeted prenatal testing or preimplantation genetic testing, depending on clinical circumstances and availability.

Australia’s healthcare system creates both support and practical variation. Public hospital genetics services may provide testing and counselling with Medicare-supported care, while some rapid prenatal tests and specialist consultations in the private market can involve substantial out-of-pocket costs. Families should ask about turnaround times, laboratory accreditation, possible gaps in Medicare coverage and the cost of follow-up testing before proceeding.

Privacy is another important consideration. Genetic information is sensitive and may affect relatives as well as the person tested. Clinicians should explain how results are stored, who can access them and when information may need to be shared for safe clinical care. The Australian Privacy Act and professional confidentiality obligations provide a framework, but families still deserve a direct explanation of consent, data use and communication with other health services.

A coordinated team can help families move through each stage without repeating the same history at every appointment. Genetic counsellors can explain inheritance, social workers can assist with travel and financial pressures, and community or hospital support services can help with bereavement or longer-term disability planning. For broader historical material on fetal medicine conferences, the ICAR 2017 resources offer another example of international professional exchange in this field.

Ask for referral to a fetal medicine and clinical genetics service when ultrasound raises concern about bone growth, mineralisation or thoracic development. Request a clear explanation of the suspected diagnosis, available testing, likely turnaround time and the limits of prenatal prediction. Early coordination gives families more time to make informed decisions and helps the obstetric and neonatal teams prepare care that matches the infant’s medical needs and the family’s values.